Fri. Oct 11, 2019 10:30 AM - 12:10 PM Room 11 (502)

Organizer / Chair: Chieko KURIHARA (National Institute for Quantum and Radiological Science and Technology, Japan), Co-chair: Kazutaka SHIMODA (Department of Psychiatry, Dokkyo Medical University, Japan), Discussants: ‌Lillian COMAS-DÍAZ (The George Washington University School of Medicine, USA), Frederick M JACOBSEN (The George Washington University School of Medicine, USA)

Mental, neurological and substance use disorders have been revealed to contribute to the Global Burden of Disease. To overcome this situation and to achieve cost-effective community care improvement respecting for human rights in various cultural contexts, evidence-based interventions including psychiatric pharmacotherapy along with community engagement and capacity development are prerequisite. Especially in recent years, in the era of global drug development and world-wide big data analysis, both of medical professionals and patients are drastically moving around the world. This has been caused by rapid development of information technology facilitating global communications, as well as the growth of easy and inexpensive transportation means. Some are seeking for better working places or better healthcare services; others are evacuating from conflict area or traveling for disaster relief. Considering such situations, we have to seek for evolutional change of drug development strategies, along with model change of community care, with enlightening perspective of psychiatric pharmacotherapy to achieve Global Mental Health.
In this symposium, speakers from Asian countries will introduce their experience in their activities to facilitate community care, including innovative psychiatric pharmacotherapy strategies, towards the achievement of Global Mental Health:
Chieko Kurihara, Senior Researcher, National Institute for Quantum and Radiological Sciences and Technology will present opening remarks of this symposium and provide a view of community care, along with global drug development and psychiatric pharmacotherapy strategies towards Global Mental Health.
Tae-Yeon Hwang, Director of Mental Health Services and Planning, National Center for Mental Health, South Korea, will introduce his activities in newly-built National Center, in their new era of revised Mental Health Act, as well as his international activities in collaborative partnership with Asian psychiatrists for facilitating community care, clinical research as well as improvement of psychiatric pharmacotherapy in each country.
Tiur Sihombing, Duren Sawit Narcotic and Mental Hospital, Indonesia, will introduce her hospital organization to provide mental health service collaborating with extensive specialists of comorbidities, such as internists, pediatricians, gynecologists, etc.(consultation liason psychiatry). Also she will introduce their engagement in rational drug use, according to guidelines, as well as community empowerment in low resource settings.
Yang Yen-Kuang, Professor of the Department of Psychiatry, National Cheng Kung University will introduce his long-standing contribution to mental health in Tainan city sometimes collaborating with local government as well as facilitating clinical trial for implementing new medications. He will show some key strategies for successful evidence-based community care, along with innovative drug development and translational research, based on his expertise and experience.
Kazutaka Shimoda, Professor, Chairman of the Department of Psychiatry, Dokkyo Medical University, will present overviewing summary of this session and closing remarks.